BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16175373)

  • 1. Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis.
    Iwase T; Iwase C
    Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):415-6. PubMed ID: 16175373
    [No Abstract]   [Full Text] [Related]  

  • 2. Subclinical myasthenia gravis causing increased sensitivity to botulinum toxin therapy.
    Dressler D
    J Neural Transm (Vienna); 2010 Nov; 117(11):1293-4. PubMed ID: 20953643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapsing-remitting severe generalized muscular weakness after botulinum toxin treatment for hyperhidrosis.
    Chiarello D; Piombo M; Corbetto M; Di Pino G; Assenza G; Capone F; Di Lazzaro V
    Muscle Nerve; 2014 Sep; 50(3):456-7. PubMed ID: 24890202
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study.
    Wein T; Jog M; Bhogal M; Dhani S; Miller R; Ismail F; Beauchamp R; Trentin G
    Can J Neurol Sci; 2019 Nov; 46(6):742-752. PubMed ID: 31256770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?
    Duarte GS; Rodrigues FB; Ferreira JJ; Costa J
    Parkinsonism Relat Disord; 2018 Nov; 56():16-19. PubMed ID: 29910156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria.
    Watts J; Brew B; Tisch S
    J Clin Neurosci; 2015 Dec; 22(12):1979-81. PubMed ID: 26188667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cosmetic botox injection mimicking myasthenia gravis.
    Sunness JS; Kelman S
    Plast Reconstr Surg; 2004 Apr; 113(5):1515. PubMed ID: 15060378
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia.
    Dressler D
    J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):604; author reply 604. PubMed ID: 12397170
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
    Fan KL; Wang YL; Chu G; Leung LP
    J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysphagia as a complication of botulinum toxin injection to treat drooling.
    Tighe D; Gok G; Moody A; Howlett D
    Br J Oral Maxillofac Surg; 2014 Sep; 52(7):673; discussion 673-4. PubMed ID: 24845119
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm.
    Roggenkämper P; Jost WH; Bihari K; Comes G; Grafe S;
    J Neural Transm (Vienna); 2006 Mar; 113(3):303-12. PubMed ID: 15959841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myaesthenia gravis exacerbation caused by axillary injection of botulinum toxin A for treatment of hyperhidrosis.
    El-Heis S; Burke G; Gibb W; Ardern-Jones MR
    Clin Exp Dermatol; 2017 Apr; 42(3):357-359. PubMed ID: 28111784
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyridostigmine for the Reversal of Severe Adverse Reactions to Botulinum Toxin in Children.
    Boerner RM; Young DL; Gnagi SH; White DR; Halstead LA
    J Pediatr; 2018 Mar; 194():241-243. PubMed ID: 29275924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysarthria Associated with Lumbar Sympathetic Block Using Botulinum Toxin.
    Carcamo CR
    Pain Med; 2019 Aug; 20(8):1634-1635. PubMed ID: 30753626
    [No Abstract]   [Full Text] [Related]  

  • 16. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
    Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
    Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
    Sloop RR; Cole D; Patel MC
    Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of dysphagia following botulinum toxin injection for neck rejuvenation.
    Phothong W; Wanitphakdeedecha R; Keskool P; Manuskiatti W
    J Cosmet Dermatol; 2017 Mar; 16(1):15-17. PubMed ID: 27637174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head drop after botox: Electrodiagnostic evaluation of iatrogenic botulinum toxicity.
    Szuch E; Caress JB; Paudyal B; Brashear A; Cartwright MS; Strowd RE
    Clin Neurol Neurosurg; 2017 May; 156():1-3. PubMed ID: 28273554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events following botulinum toxin type A treatment in children with cerebral palsy.
    Langdon K; Blair E; Davidson SA; Valentine J
    Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.